Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC26A3 |
| Upstream (Parents) |
|---|
| (<<) ASCL2 → SLC26A3 |
| (<<) SATB2 → SLC26A3 |
| (<<) CDX2 → SLC26A3 |
| (<<) SOX2 → SLC26A3 |
| (<<) ETV4 → SLC26A3 |
| (<<) PITX2 → SLC26A3 |
| (<<) GRHL2 → SLC26A3 |
| (<<) CEBPD → SLC26A3 |
| (<<) TFCP2L1 → SLC26A3 |
| (<<) NR6A1 → SLC26A3 |
| (<<) PLAG1 → SLC26A3 |
| (<<) TRIM22 → SLC26A3 |
| (<<) PLAGL2 → SLC26A3 |
| (<<) STAT1 → SLC26A3 |
| (<<) GTF2IRD1 → SLC26A3 |
| (<<) TCF7 → SLC26A3 |
| Downstream (Children) |
|---|
| SLC26A3 → TAF4 (>>) |
| SLC26A3 → TBX6 (>>) |
| SLC26A3 → TSC22D4 (>>) |
| SLC26A3 → VAX2 (>>) |
| SLC26A3 → HEYL (>>) |
| SLC26A3 → FOXD2 (>>) |
| SLC26A3 → PBX2 (>>) |
| SLC26A3 → EGR1 (>>) |
